Literature DB >> 15946178

Molecular pathogenesis of oral submucous fibrosis--a collagen metabolic disorder.

P Rajalalitha1, S Vali.   

Abstract

Oral submucous fibrosis (OSF) is a chronic debilitating disease and a premalignant condition of the oral cavity. It is characterized by a generalized submucosal fibrosis. The pathogenesis of the disease is not well established. Epidemiological evidences strongly indicate the association of the betel quid (BQ) habit and OSF. Various findings indicate the disease to be a consequence of disturbances in the homeostatic equilibrium between synthesis and degradation of extracellular matrix (ECM), wherein collagen forms a major component, thus can be considered as a collagen-metabolic disorder. Transforming growth factor-beta (TGF-beta) is a potent stimulator of production and deposition of the ECM. The objectives of this review are to highlight the molecular events involved in the overproduction of insoluble collagen and decreased degradation of collagen occurring via exposure to BQ and stimulation of the TGF-beta pathway, and elucidate the cell signaling that is involved in the etiopathogenesis of the disease process.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15946178     DOI: 10.1111/j.1600-0714.2005.00325.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  89 in total

1.  Oral submucous fibrosis: a clinicopathologic review of 205 cases in Indians.

Authors:  Punnya V Angadi; K P Rekha
Journal:  Oral Maxillofac Surg       Date:  2011-03

2.  Architectural Analysis of Picrosirius Red Stained Collagen in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma using Polarization Microscopy.

Authors:  Rashi Sharma; Shweta Rehani; Monica Mehendiratta; Priyanka Kardam; Madhumani Kumra; Yulia Mathias; Jyoti Yadav; Khushboo Sahay
Journal:  J Clin Diagn Res       Date:  2015-12-01

3.  Histochemical analysis of polarizing colors of collagen using Picrosirius Red staining in oral submucous fibrosis.

Authors:  Surekha Velidandla; Pravin Gaikwad; Kranti Kiran Reddy Ealla; Kavitha D Bhorgonde; Prahalad Hunsingi; Anoop Kumar
Journal:  J Int Oral Health       Date:  2014-02-26

4.  Alteration of Serum Lipid in Oral Sub Mucous Fibrosis in Central India.

Authors:  J K Yashveer; Devendra Pankaj
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-06-28

5.  Evaluation of myofibroblasts by expression of alpha smooth muscle actin: a marker in fibrosis, dysplasia and carcinoma.

Authors:  Bharath Rao K; N Malathi; Sangeetha Narashiman; Sharada T Rajan
Journal:  J Clin Diagn Res       Date:  2014-04-15

Review 6.  Management of oral submucous fibrosis: an overview.

Authors:  Punnya V Angadi; Sanjay Rao
Journal:  Oral Maxillofac Surg       Date:  2010-09

7.  Treatment of oral submucous fibrosis using split skin graft and a polyethylene stent: a prospective study.

Authors:  Chen Loong Soh; M R Muthusekhar
Journal:  J Maxillofac Oral Surg       Date:  2014-08-13

Review 8.  Proposed clinical definition for oral submucous fibrosis.

Authors:  Chandramani B More; Naman R Rao
Journal:  J Oral Biol Craniofac Res       Date:  2019-07-02

9.  Correlation of Clinical and Histopathological Grades in Oral Submucous Fibrosis Patients with Oxidative Stress Markers in Saliva.

Authors:  C V Divyambika; S Sathasivasubramanian; G Vani; A J Vanishree; N Malathi
Journal:  Indian J Clin Biochem       Date:  2017-09-13

10.  Evaluation of plasma fibrinogen degradation products and total serum protein concentration in oral submucous fibrosis.

Authors:  Megha Kadani; Satish B N V S; Maharudrappa B; Prashant K M; Deepa Hugar; Umesh Allad; Prasanth S Prabhu
Journal:  J Clin Diagn Res       Date:  2014-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.